No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 56.240
- +1.680+3.08%
Close Jul 22 16:00 ET
- 56.230
- -0.010-0.02%
Pre 05:33 ET
4.78BMarket Cap-20829P/E (TTM)
56.390High54.060Low1.21MVolume55.200Open54.560Pre Close67.09MTurnover1.45%Turnover RatioLossP/E (Static)84.92MShares91.10052wk High2.29P/B4.69BFloat Cap37.55052wk Low--Dividend TTM83.37MShs Float220.200Historical High--Div YieldTTM4.27%Amplitude11.630Historical Low55.461Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Agilent to Acquire North American CDMO BIOVECTRA
Institutional Investors Must Be Pleased After a 8.9% Gain Last Week That Adds to CRISPR Therapeutics AG's (NASDAQ:CRSP) One-year Returns
CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?
CRISPR Therapeutics (NASDAQ:CRSP) Adds US$359m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 54%
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Ark's Cathie Wood Blasts Big Tech. She Prefers Palantir and These Other Stocks.
Comments
$CRISPR Therapeutics(CRSP.US$ Today good 😍😍😍
1
$CRISPR Therapeutics(CRSP.US$ ok what happened
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
